These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 30014466)
1. Reduced expression of the RNA-binding protein HuD in pancreatic neuroendocrine tumors correlates with low p27 Kim C; Jeong DE; Heo S; Ji E; Rho JG; Jung M; Ahn S; Kim YJ; Kim YS; Nam SW; Kulkarni RN; Lee KB; Lee EK; Kim W J Pathol; 2018 Oct; 246(2):231-243. PubMed ID: 30014466 [TBL] [Abstract][Full Text] [Related]
2. A miR-194/PTBP1/CCND3 axis regulates tumor growth in human hepatocellular carcinoma. Kang H; Heo S; Shin JJ; Ji E; Tak H; Ahn S; Lee KJ; Lee EK; Kim W J Pathol; 2019 Nov; 249(3):395-408. PubMed ID: 31301177 [TBL] [Abstract][Full Text] [Related]
3. RNA binding protein HuD and microRNA-203a cooperatively regulate insulinoma-associated 1 mRNA. Kim C; Ahn S; Lee EK Biochem Biophys Res Commun; 2020 Jan; 521(4):971-976. PubMed ID: 31722792 [TBL] [Abstract][Full Text] [Related]
4. MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27(kip1). Sun M; Liu XH; Li JH; Yang JS; Zhang EB; Yin DD; Liu ZL; Zhou J; Ding Y; Li SQ; Wang ZX; Cao XF; De W Mol Cancer Ther; 2012 Apr; 11(4):842-52. PubMed ID: 22343731 [TBL] [Abstract][Full Text] [Related]
6. Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer. Li Z; Tao Y; Wang X; Jiang P; Li J; Peng M; Zhang X; Chen K; Liu H; Zhen P; Zhu J; Liu X; Liu X Cell Physiol Biochem; 2018; 51(2):610-629. PubMed ID: 30458449 [TBL] [Abstract][Full Text] [Related]
7. Reciprocal antagonistic regulation of N-myc mRNA by miR‑17 and the neuronal-specific RNA-binding protein HuD. Samaraweera L; Spengler BA; Ross RA Oncol Rep; 2017 Jul; 38(1):545-550. PubMed ID: 28560387 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells. Dong Q; Li C; Che X; Qu J; Fan Y; Li X; Li Y; Wang Q; Liu Y; Yang X; Qu X Oncotarget; 2016 Dec; 7(50):82338-82353. PubMed ID: 27494897 [TBL] [Abstract][Full Text] [Related]
10. Higd-1a regulates the proliferation of pancreatic cancer cells through a pERK/p27 An HJ; Ryu M; Jeong HJ; Kang M; Jeon HM; Lee JO; Kim YS; Lee H Cancer Lett; 2019 Oct; 461():78-89. PubMed ID: 31310799 [TBL] [Abstract][Full Text] [Related]
11. miR-196a-mediated downregulation of p27 Zhan B; Huang L; Chen Y; Ye W; Li J; Chen J; Yang S; Jiang W Prostate; 2020 Sep; 80(12):1024-1037. PubMed ID: 32628792 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-215 functions as a tumor suppressor and directly targets ZEB2 in human pancreatic cancer. Li QW; Zhou T; Wang F; Jiang M; Liu CB; Zhang KR; Zhou Q; Tian Z; Hu KW Genet Mol Res; 2015 Dec; 14(4):16133-45. PubMed ID: 26662405 [TBL] [Abstract][Full Text] [Related]
13. PCBP1 depletion promotes tumorigenesis through attenuation of p27 Shi H; Li H; Yuan R; Guan W; Zhang X; Zhang S; Zhang W; Tong F; Li L; Song Z; Wang C; Yang S; Wang H J Exp Clin Cancer Res; 2018 Aug; 37(1):187. PubMed ID: 30086790 [TBL] [Abstract][Full Text] [Related]
17. The RNA-binding protein, HuD regulates proglucagon biosynthesis in pancreatic α cells. Ahn S; Tak H; Kang H; Ryu S; Jeong SM; Kim W; Lee EK Biochem Biophys Res Commun; 2020 Sep; 530(1):266-272. PubMed ID: 32828297 [TBL] [Abstract][Full Text] [Related]
18. p27 Kip1 expression is reduced in pancreatic carcinoma but has limited prognostic value. Feakins RM; Ghaffar AH Hum Pathol; 2003 Apr; 34(4):385-90. PubMed ID: 12733121 [TBL] [Abstract][Full Text] [Related]
19. RNA-binding protein HuD controls insulin translation. Lee EK; Kim W; Tominaga K; Martindale JL; Yang X; Subaran SS; Carlson OD; Mercken EM; Kulkarni RN; Akamatsu W; Okano H; Perrone-Bizzozero NI; de Cabo R; Egan JM; Gorospe M Mol Cell; 2012 Mar; 45(6):826-35. PubMed ID: 22387028 [TBL] [Abstract][Full Text] [Related]
20. Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer. Juuti A; Nordling S; Louhimo J; Lundin J; von Boguslawski K; Haglund C Oncology; 2003; 65(4):371-7. PubMed ID: 14707458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]